Telix Pharmaceuticals Limited · ASX:TLX
Smith Darren Charlton exercised options for 1,111 Telix Pharmaceuticals Limited shares (Form 4)
Traded Mar 29, 2026 · Filed Apr 1, 2026
On Mar 29, 2026, Smith Darren Charlton (Group Chief Financial Officer) exercised options for 1,111 Telix Pharmaceuticals Limited shares, leaving 11,921 shares. Filed Apr 1, 2026 (Form 4).
- Options exercised
- 1,111 shares
- Holding after
- 11,921 shares
- Trading plan
- No
- Role
- Group Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 29, 2026 | Ordinary Shares | Option exercise | 1,111 | 11,921 | Direct |